Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Pediatrix Medical Group, Inc.
Next earnings Aug 3, 2026 (before open) · consensus $0.61 EPS, $493M rev
Last earnings -7.1% on 2026-05-05
Undemanding valuation (P/E 12.3); but revenue declined -4.9% YoY.
Sources: SEC EDGAR (CIK 0000893949, latest 10-Q filed 2026-05-05) · EODHD · as of 6/22/2026, 1:51:00 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
It screens cheap (~208% below fair value), but the weak fundamentals are why — more potential value trap than bargain.
Pediatrix Medical Group, Inc. shows $1.91B in FY2025 revenue (-4.9% YoY), a 8.6% net margin, and 19.1% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.91B | $1.97B | $1.99B | $2.01B | $1.91B |
| Gross profit | — | — | — | — | — |
| Operating income | $203M | $173M | $7.32M | -$68.7M | $209M |
| Net income | $131M | $66.3M | -$60.4M | -$99.1M | $165M |
| Diluted EPS | $1.53 | $0.79 | -$0.73 | -$1.19 | $1.94 |
| Net margin | 6.9% | 3.4% | -3.0% | -4.9% | 8.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-09 | Moore Mary Ann E EVP, GC, Chief Admin Off & Sec | Gift | 18.4K | |
| 2026-06-09 | Moore Mary Ann E EVP, GC, Chief Admin Off & Sec | Gift | 18.4K | |
| 2026-06-02 | ORDAN MARK S Chief Executive Officer | Disposed (D) | 97.2K | |
| 2026-06-02 | ORDAN MARK S Chief Executive Officer | Award | 97.2K | |
| 2026-06-01 | Rossi Kasandra H EVP, CFO and Treasurer | Award | 31.8K | |
| 2026-06-01 | Rossi Kasandra H EVP, CFO and Treasurer | Tax | 3.70K @ $21.54 | $79.7K |
| 2026-06-01 | ORDAN MARK S Chief Executive Officer | Award | 127K | |
| 2026-06-01 | ORDAN MARK S Chief Executive Officer | Tax | 19.1K @ $21.54 | $412K |
| 2026-06-01 | Neeb Don Gregory EVP, Chief Invest & Strategy | Award | 63.9K | |
| 2026-06-01 | Neeb Don Gregory EVP, Chief Invest & Strategy | Tax | 8.00K @ $21.54 | $172K |
| 2026-06-01 | Moore Mary Ann E EVP, GC, Chief Admin Off & Sec | Tax | 11.9K @ $21.54 | $257K |
| 2026-05-13 | Weis Shirley A Director | Sell | 36.0K @ $23.75 | $856K |